Skip main navigation
×

American Heart Association and the Global COVID-19 Pandemic

Coronavirus

NEW: Cerebral Venous Sinus Thrombosis and COVID-19

From the American Heart Association President's Page (March 17, 2020):
As the United States and the world confront the novel coronavirus (COVID-19) pandemic, the American Heart Association (AHA) and its thousands of science volunteers have an important role to play to help stop the spread.

That may seem counterintuitive to some, considering COVID-19 is an infectious disease and the AHA has spent the last nearly 100 years focused on noncommunicable diseases such as cardiovascular diseases, stroke and other vascular disorders. However, COVID-19 is very much a concern of the AHA, because patients with underlying cardiovascular conditions appear to face greater risk of complications. And, as an organization dedicated to overall health and well-being, we are very concerned about significant domestic and global health problems. Continue reading the American Heart Association President's Page...

Statements from the American Heart Association

HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19

CVST and blood clots potentially related to the J&J COVID-19 vaccine: know the symptoms

For up-to-date information regarding the American Heart Association's response to the global COVID-19 pandemic, see Professional Heart Daily featuring a new AHA Compendium of COVID-19 Content.



AHA/ASA Articles on COVID-19

See all

Circulation Video Series: COVID Updates From the Front Lines

23 March 2020

Introduction